← REGULATORY CHANGES
FEDERAL REGISTER · NOTICEMarch 18, 2024
Early Alzheimer's Disease: Developing Drugs for Treatment; Draft Guidance for Industry; Availability
Document type
Notice
Agency
Health and Human Services Department
Published
March 18, 2024
Document number
C1-2024-05178
PROFESSIONAL CHANGE REPORT
See the structure of SPEQ’s reviewed analysis
Explorer members can open three bounded, human-reviewed previews each month. Full relationships, analysis, and implementation implications remain protected.
Sign in free to preview →READ THE FULL DOCUMENT
The complete document — every provision, the docket, and the comment instructions — is published in the Federal Register. SPEQ surfaces and indexes it for reference; the authoritative text lives on federalregister.gov.
View on federalregister.gov →PUT THIS CHANGE TO WORK
Document details are published in the U.S. Federal Register; SPEQ surfaces them for reference and is not affiliated with or endorsed by the FDA or the Office of the Federal Register. The authoritative text is on federalregister.gov.